ALCON INC
ALC- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001167379
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
635
- −22 vs. Q1 2026
- Total value $94.54B
Superinvestors holding ALC
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by ALC insiders, newest first.
No open-market purchases or sales by ALC insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in ALC at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 1,158,270 | $78.4B | 10.86% | +35,148+3.1% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 14,749,582 | $994.56M | 0.02% | −122,025−0.8% | Reduced |
| Bank of New York Mellon Corp | 13,057,962 | $876.19M | 0.14% | −2,611,700−16.7% | Reduced |
| NORGES BANK | 10,976,697 | $741.43M | 0.07% | +10,976,697 | New |
| Invesco Ltd. | 10,380,332 | $696.52M | 0.06% | +10,020,691+2,786.3% | Added |